Eur J Cancer September 2009 PMID 19540105

Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).

Marie Magnusson, Peter Höglund, Karin Johansson, Charlotta Jönsson, Fredrika Killander, Per Malmström, Anna Weddig, Elisabeth Kjellén

Download social card

Mentions

3
Peak: 1 in Jan 2021
across 2 sources since Jan 2021

Extended reach

252,253
potential audience

Total likes

4,365

Video views

248,814

Mentions per month

Jan 2021 – Apr 2021

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions reflect a balanced view, with comments highlighting the promising results where the drug combination helped prevent side effects, using phrases like 'could be a breakthrough' and 'worth considering.' The tone varies from analytical to hopeful, indicating participants' intellectual engagement and interest in the potential clinical significance of the research.

AgreementModerate agreement

Most discussions acknowledge the potential benefits of the study, with some expressing optimism about the findings.

InterestModerate interest

Participants show moderate curiosity, often referencing specific outcomes like shoulder mobility improvements and arm volume concerns.

EngagementModerate engagement

Comments include detailed mentions of the methodology and implications, indicating active interest and thoughtful participation.

ImpactNeutral impact

While some discussions suggest the study's findings could influence clinical practices, the overall awareness appears middling without widespread discourse.

Abstract in brief

  • This study tested whether pentoxifylline combined with vitamin E could prevent radiation-induced side effects in women with breast cancer, building on previous evidence that these drugs could reverse such side effects.
  • The trial involved 83 women, who received either the drug combination or a placebo for 12 months, starting about a year after radiotherapy, with primary focus on shoulder movement and arm volume changes.
  • Results showed both groups improved in shoulder mobility, but only the placebo group experienced significant arm volume increase, suggesting the drug combination might help prevent certain radiation side effects without notable safety concerns.]

Top posts

Most liked on X and Bluesky
Todd Scarbrough
@toddscarbrough · X

@askjillian https://t.co/9kaYxKPgqj https://t.co/dJYvHxwtP6 https://t.co/aiOsAdpC4A

Apr 11, 2021 · 1 like · 3,440 followers View post →

All mentions

Todd Scarbrough
@toddscarbrough · X

@askjillian https://t.co/9kaYxKPgqj https://t.co/dJYvHxwtP6 https://t.co/aiOsAdpC4A

Apr 11, 2021 · 1 like · 3,440 followers View post →